Biogennix

FDA Regulatory Profile

Biogennix appears in FDA public data with 0 recalls, 9 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent FDA inspection ended on Feb 8, 2024 (No Action Indicated (NAI)). Its most recent 510(k) clearance was granted on Apr 30, 2024.

Reviewing Biogennix as a supplier? Get its full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.

Get a free API key

Summary

Total Recalls
0
510(k) Clearances
9
Inspections
3
Compliance Actions
0

Recent FDA Inspections

DateSiteProductClassificationFEI
Feb 8, 2024Irvine, CADevicesNo Action Indicated (NAI)3008773560
Jul 29, 2016Irvine, CADevicesNo Action Indicated (NAI)3008773560
Apr 18, 2012Irvine, CADevicesNo Action Indicated (NAI)3008773560

FDA Data Dashboard classifications: NAI (no action indicated), VAI (voluntary action indicated), OAI (official action indicated).

Recent 510(k) Clearances

K-NumberDeviceDate
K240621Morpheus® Moldable; Agilon® MoldableApr 30, 2024
K193487Agilon StripMar 30, 2020
K193168Agilon MoldableFeb 13, 2020
K190371Morpheus-CAug 9, 2019
K181337Sypher Spacer SystemSep 18, 2018
K141798SYPHER SPACER SYSTEMFeb 19, 2015
K142828osteoSPAN MorpheusJan 15, 2015
K132377OSTEOSPAN MORPHEUSMay 20, 2014
K093342BIOGENNIX RPCJul 29, 2010